Bridgeway Capital Management’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,096
Closed -$210K 1338
2021
Q2
$210K Sell
2,096
-1,168
-36% -$121K ﹤0.01% 1253
2021
Q1
$416K Sell
3,264
-558
-15% -$82.5K 0.01% 1142
2020
Q4
$425K Sell
3,822
-454
-11% -$50.8K 0.01% 1006
2020
Q3
$503K Buy
4,276
+2,603
+156% +$450K 0.01% 884
2020
Q2
$359K Sell
1,673
-505
-23% -$119K 0.01% 974
2020
Q1
$491K Buy
2,178
+1,644
+308% +$469K 0.01% 771
2019
Q4
$143K Buy
534
+250
+88% +$62.9K ﹤0.01% 1229
2019
Q3
$86K Hold
284
﹤0.01% 1254
2019
Q2
$94K Sell
284
-227
-44% -$115K ﹤0.01% 1249
2019
Q1
$320K Sell
511
-318
-38% -$145K ﹤0.01% 1136
2018
Q4
$206K Hold
829
﹤0.01% 1213
2018
Q3
$385K Buy
829
+511
+161% +$248K ﹤0.01% 1200
2018
Q2
$173K Hold
318
﹤0.01% 1317
2018
Q1
$182K Buy
+318
New +$201K ﹤0.01% 1277

Other funds holding RMTI

Bridgeway Capital Management's RMTI Position: Q3 2021 in Review

Bridgeway Capital Management sold out of Rockwell Medical (RMTI) in Q3 2021, closing a stake of 2,096 shares — an estimated $210K sold.

Bridgeway Capital Management first reported a position in RMTI in Q1 2018 and held it in 14 quarters. The position peaked at $503K in Q3 2020. 62 funds tracked by Wall St. Rank hold RMTI as of Q3 2021.

  • Bridgeway Capital Management reported no remaining Rockwell Medical position as of Q3 2021 after selling out during the quarter.
  • Bridgeway Capital Management sold 2,096 Rockwell Medical shares in Q3 2021, an estimated $210K.
  • Bridgeway Capital Management first reported a position in Rockwell Medical in Q1 2018 and held it in 14 quarters.
  • Bridgeway Capital Management's Rockwell Medical position peaked at $503K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2021.

Based on Bridgeway Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.